Previous 10 | Next 10 |
Gainers Bakkt Holdings (NYSE:BKKT) +30%. Kaival Brands Innovations Group (NASDAQ:KAVL) +29%. CF Acquisition (NASDAQ:CFVIU) +21%. CF Acquisition (NASDAQ:CFVI) +19%. Origin Agritech (NASDAQ:SEED) +20%. Phunware (NASDAQ:PHUN) +19%. IceCure Medical (NASDAQ:ICCM) +17%. Peloton Interactive (NASDAQ:...
Shares of Adagio Therapeutics (NASDAQ: ADGI) jumped 25.9% on Thursday. The stock closed at $5.55 a share on Wednesday, opened at $5.62 on Thursday, and hit a midday high of $6.99 before closing at $6.44. The stock has been quite volatile, with a 52-week range between $4.92 and $...
5 Biotech Stocks For Your Mid-January 2022 Watchlist Biotech stocks have often been a popular theme in the stock market . Even without the catalyst from the ongoing pandemic, the industry is one that many investors keep a close tab on. Now, why is that so? For starters, biotech ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re starting off the day right with a look at the biggest pre-market stock movers for Thursday! Source: f11photo/Shutterstock.com We’re seeing loads of movement from ETFs this...
Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron Multiple Efforts Underway to Address Omicron and Potential Future SARS-CoV-2 Variants WALTHAM, Mass...
WALTHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced tha...
One of the more disappointing biotech stocks of recent weeks, Adagio Therapeutics (NASDAQ: ADGI) , was hammered once again on Wednesday, with its share price tumbling by over 13%. This followed a fresh analyst downgrade of the stock, one of several that have occurred lately. The...
Tesla (NASDAQ:TSLA) highlighted Wednesday's midday trading, as the electric-vehicle maker jumped after Elon Musk signaled an end to his string of stock sales. Analyst comments also shared in the spotlight during intraday action. Caterpillar (NYSE:CAT) saw gains in the wake of an upgrade, whil...
After enjoying a sharp turnaround in its share price last week, Adagio Therapeutics (ADGI -15.3%) is continuing its downward trajectory after Jefferies added another bearish view for the stock, cutting its rating to Hold from Buy. The analyst Michael Yee points to uncertainty over the future ...
Gainers: Society Pass (NASDAQ:SOPA) +237%. Bluerock Residential Growth (NYSE:BRG) +71%. Can-Fite (NYSE:CANF) +59%. AeroClean (NASDAQ:AERC) +58%. Galera Therapeutics (NASDAQ:GRTX) +38%. Verso (NYSE:VRS) +35%. Roivant (NASDAQ:ROIV) +26%. Venus (NASDAQ:VERO) +25%. BioCardia (NASDAQ:BCDA) +1...
News, Short Squeeze, Breakout and More Instantly...
Adagio Therapeutics Inc. Company Name:
ADGI Stock Symbol:
NASDAQ Market:
WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that as part of the annual reconstitution of the Russell stock indexes, Invivyd will be included in ...
Pseudovirus in vitro neutralization data show continued neutralizing activity of VYD222 (pemivibart) against the KP.1.1 FLiRT and KP.3 SARS-CoV-2 variants, virus selections representative of current dominant strains and the most recent FLiRT-containing viruses Invivyd’s new data is...
WALTHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that its management team is scheduled to participate in a fireside chat at the Jefferies Global Heal...